Why colorectal cancer genetics matter in Bangladesh
What studying KRAS, PIK3CA and PTEN in Bangladeshi patients taught me about the gaps in global cancer data.
Read post →Researcher and Erasmus Mundus Master's student in Innovative Medicine, studying the molecular basis of cancer. Between the lab bench and the microscope, I also write and take photographs.
I'm an Erasmus Mundus Joint Master's student in Innovative Medicine (IMIM). After my first year at Uppsala University in Sweden, I'm now continuing at the University of Tartu in Estonia. My foundation is in Genetic Engineering and Biotechnology, with both a Bachelor's and a Master's from the University of Chittagong, Bangladesh.
My research interests centre on molecular oncology: the genetic changes that drive cancer, and how we can detect them earlier and more precisely. I have studied driver-gene mutations in Bangladeshi colorectal and breast cancer patients, developed proximity ligation assays at SciLifeLab, and explored cGAS–STING signalling in tumour immunology.
I work across both wet-lab and computational research, from PCR, sequencing and immunohistochemistry to R and bioinformatics. Beyond the lab, I've spent years writing about cancer for the public, and I enjoy telling stories through photography.
From population genetics of colorectal cancer to assay development and tumour immunology.
Ulf Landegren Group, SciLifeLab · Uppsala, Sweden
ProjectDevelopment of an Antibody Proximity Ligation Assay (AbPLA) for detection of anti-La autoantibodies in systemic lupus erythematosus
SupervisorMarcus Danielsson
Mats Hellström Group (Neuro-oncology Lab), Dept. of Immunology, Genetics and Pathology, Uppsala University
ProjectEvaluation of cGAMP-induced interferon-β responses in EL4 tumour cell and splenocyte co-cultures via the cGAS–STING pathway
Functional Genomics and Proteomics Laboratory, University of Chittagong, Bangladesh
ThesisAssociation of KRAS, PIK3CA, PTEN and ETS-1 genes with colorectal cancer and their correlation with clinicopathological and lifestyle factors in the Bangladeshi population
SupervisorProfessor Dr. Mohammad Al-Forkan
Department of Histopathology and Cytopathology, Ahsania Mission Cancer & General Hospital · Dhaka
SupervisorProf. Dr. Md. Zillur Rahman
University of Tartu, Estonia · Innovation in Bioengineering
Uppsala University, Sweden · Innovative Medicine
University of Chittagong, Bangladesh
University of Chittagong, Bangladesh
Association of p53 codon 72 polymorphisms with expression status of hormone receptors like ER, PR, and HER-2 in invasive ductal breast carcinoma in Bangladeshi women
Rahman MZ, Alam MJ, Bhattacharjee A, Riyaz MAR, Wali FB, Shawon II, … Al-Forkan M.
Bangabandhu Sheikh Mujib Medical University Journal, 18(3), e80619
Writing on cancer science, research life, and studying across Europe.
What studying KRAS, PIK3CA and PTEN in Bangladeshi patients taught me about the gaps in global cancer data.
Read post →Building a proximity ligation assay, and what I learned about doing science in a Swedish research group.
Read post →Reflections on moving across three countries for science, and advice for students applying to Erasmus Mundus.
Read post →Places, people and small moments from Bangladesh, Sweden, Estonia and beyond.






More on Instagram @azizur.riyaz
I'm always happy to hear from researchers, clinicians and fellow students interested in cancer biology, molecular diagnostics or translational medicine, and I'm open to Master's thesis opportunities.